Abstract Titles

Skip to Late-Breaking Abstracts »

All accepted abstracts will be available in the Journal for ImmunoTherapy of Cancer (JITC).

Abstract Titles

Onsite Posters

Onsite posters will be presented in the Poster Hall at the Walter E. Washington Convention Center in Washington, D.C. All odd numbered posters will be presented on Friday, Nov. 12, 2021. Even numbered posters will be presented Saturday, Nov. 13, 2021.

ePosters

ePosters will be on display on the SITC 2021 virtual meeting platform from 7 a.m. EST on Friday, Nov. 12, 2021 until the virtual meeting platform is closed on Jan. 9, 2022.


Search word or phrase:

# Type Title Authors Category Keywords
366 Poster Presentation Combined exploratory immunophenotyping and transcriptomic tumor analysis in patients treated with OSE2101 vaccine in HLA-A2+ advanced non-small cell lung cancer (NSCLC) from the ATALANTE-1 trial Santiago Viteri, MD; Werner Hilgers; Fabrice Denis; Elisabeth Quoix, MD; Gilles Robinet, MD; Enriqueta Felip, MD, PhD; Rafal Dziadziuszko, MD; Nicolas Poirier; Claudia Fromond, PhD; Isabelle Girault; Thomas Vandewalle; Dominique Costantini, MD; Bérangère Vasseur, MD; Federico Cappuzzo, MD; Giuseppe Giaccone, MD; Benjamin Besse, MD, PhD Clinical Trials Completed Biomarkers;Checkpoint blockade;Clinical study;Clinical trial;Immune monitoring;Immunoscore;Solid tumors;Tumor antigens;Tumor microenvironment;Vaccine